tirzepatide lean‑body‑mass decline

tirzepatide lean‑body‑mass decline

Hidden Cost of Tirzepatide’s Lean‑Body‑Mass Loss vs Semaglutide

Hidden Cost of Tirzepatide’s Lean-Body-Mass Loss vs Semaglutide Unexpectedly, routine care shows a 30% higher lean-body-mass decline with tirzepatide compared with semaglutide, meaning patients lose more muscle while shedding fat. This hidden cost matters because muscle loss can undermine long-term health and functional independence, especially in older adults. Medical